|
1
|
Clinical end points and response criteria in mycosis fungoides and Sézary syndrome: a consensus statement of the International Society for Cutaneous Lymphomas, the United States Cutaneous Lymphoma Consortium, and the Cutaneous Lymphoma Task Force of the European Organisation for Research and Treatment of Cancer.
|
J Clin Oncol
|
2011
|
1.85
|
|
2
|
Prognostic factors in primary cutaneous B-cell lymphoma: the Italian Study Group for Cutaneous Lymphomas.
|
J Clin Oncol
|
2006
|
1.70
|
|
3
|
microRNA-214 contributes to melanoma tumour progression through suppression of TFAP2C.
|
EMBO J
|
2011
|
1.66
|
|
4
|
Clinical experience with ipilimumab 3 mg/kg: real-world efficacy and safety data from an expanded access programme cohort.
|
J Transl Med
|
2014
|
1.59
|
|
5
|
Update on erythrodermic cutaneous T-cell lymphoma: report of the International Society for Cutaneous Lymphomas.
|
J Am Acad Dermatol
|
2002
|
1.54
|
|
6
|
Skin cancers and other cutaneous diseases in renal transplant recipients: a single Italian center observational study.
|
Eur J Dermatol
|
2011
|
1.43
|
|
7
|
Cytotoxic/natural killer cell cutaneous lymphomas. Report of EORTC Cutaneous Lymphoma Task Force Workshop.
|
Cancer
|
2003
|
1.15
|
|
8
|
Sequential treatment with ipilimumab and BRAF inhibitors in patients with metastatic melanoma: data from the Italian cohort of the ipilimumab expanded access program.
|
Cancer Invest
|
2014
|
1.06
|
|
9
|
Zosteriform cutaneous metastases: a literature meta-analysis and a clinical report of three melanoma cases.
|
Dermatol Surg
|
2009
|
1.03
|
|
10
|
Electrochemotherapy in the treatment of Kaposi sarcoma cutaneous lesions: a two-center prospective phase II trial.
|
Ann Surg Oncol
|
2011
|
1.01
|
|
11
|
The Sézary syndrome: hematologic criteria.
|
Hematol Oncol Clin North Am
|
2003
|
0.96
|
|
12
|
Skin metastases of malignant melanoma: a clinical and prognostic survey.
|
Melanoma Res
|
2009
|
0.96
|
|
13
|
Melanoma of unknown primary site: a 33-year experience at the Turin Melanoma Centre.
|
Melanoma Res
|
2010
|
0.95
|
|
14
|
Serum levels of the Th1 promoter IL-12 and the Th2 chemokine TARC are elevated in erythema multiforme and Stevens-Johnson syndrome/toxic epidermal necrolysis and correlate with soluble Fas ligand expression. An immunoenzymatic study from the Italian Group of Immunopathology.
|
Dermatology
|
2007
|
0.93
|
|
15
|
Adjuvant ganglioside GM2-KLH/QS-21 vaccination versus observation after resection of primary tumor > 1.5 mm in patients with stage II melanoma: results of the EORTC 18961 randomized phase III trial.
|
J Clin Oncol
|
2013
|
0.92
|
|
16
|
Therapeutic hotline. A rare vandetanib-induced photo-allergic drug eruption.
|
Dermatol Ther
|
2010
|
0.91
|
|
17
|
Efficacy and safety of ipilimumab in elderly patients with pretreated advanced melanoma treated at Italian centres through the expanded access programme.
|
J Exp Clin Cancer Res
|
2014
|
0.89
|
|
18
|
Gemcitabine as frontline treatment for cutaneous T-cell lymphoma: phase II study of 32 patients.
|
Cancer
|
2005
|
0.88
|
|
19
|
Time course, clinical pathways, and long-term hazards risk trends of disease progression in patients with classic mycosis fungoides: a multicenter, retrospective follow-up study from the Italian Group of Cutaneous Lymphomas.
|
Cancer
|
2012
|
0.87
|
|
20
|
Functional and phenotypical impairment of polymorphonuclear cells in atopic dermatitis: an additional cause for the known susceptibility to infections?.
|
Dermatology
|
2012
|
0.85
|
|
21
|
Diagnostic and therapeutic approaches in Italian hospitals: adjuvant and metastatic therapy in melanoma.
|
Dermatology
|
2013
|
0.83
|
|
22
|
Expression pattern of chemokine receptors and chemokine release in inflammatory erythroderma and Sézary syndrome.
|
Dermatology
|
2006
|
0.81
|
|
23
|
RT-PCR tyrosinase expression in the peripheral blood of melanoma patients.
|
Expert Rev Mol Diagn
|
2004
|
0.81
|
|
24
|
Cholesteryl butyrate solid lipid nanoparticles as a butyric acid pro-drug: effects on cell proliferation, cell-cycle distribution and c-myc expression in human leukemic cells.
|
Anticancer Drugs
|
2004
|
0.80
|
|
25
|
FoxP3 expression on melanoma cells is related to early visceral spreading in melanoma patients treated by electrochemotherapy.
|
Pigment Cell Melanoma Res
|
2011
|
0.79
|
|
26
|
Cutaneous melanoma metastases arising on a split-skin graft donor site.
|
Dermatol Surg
|
2009
|
0.78
|
|
27
|
Imatinib mesylate in the treatment of a large unresectable dermatofibrosarcoma protuberans: a case study.
|
Dermatol Surg
|
2006
|
0.78
|
|
28
|
Functional and phenotypical alterations of polymorphonuclear cells in Sézary syndrome patients.
|
Eur J Dermatol
|
2012
|
0.77
|
|
29
|
Thymopentin down-regulates both activity and expression of iNOS in blood cells of Sézary syndrome patients.
|
Nitric Oxide
|
2012
|
0.77
|
|
30
|
Expression of AP-2α, AP-2γ and ESDN in primary melanomas: correlation with histopathological features and potential prognostic value.
|
J Dermatol Sci
|
2012
|
0.77
|
|
31
|
Prognostic relevance of baseline and sequential peripheral blood tyrosinase expression in 200 consecutive advanced metastatic melanoma patients.
|
Melanoma Res
|
2007
|
0.77
|
|
32
|
Italian Euromelanoma Day Screening Campaign (2005-2007) and the planning of melanoma screening strategies.
|
Eur J Cancer Prev
|
2012
|
0.77
|
|
33
|
Sentinel lymph node dissection in stage I/II melanoma patients: surgical management and clinical follow-up study.
|
Melanoma Res
|
2004
|
0.76
|
|
34
|
Intralesional cidofovir for the treatment of multiple and recalcitrant cutaneous viral warts.
|
Dermatol Ther
|
2012
|
0.76
|
|
35
|
Effectiveness of electrochemotherapy in treatment of a recurrent squamous cell carcinoma of the scalp.
|
Eur J Dermatol
|
2011
|
0.75
|
|
36
|
Effectiveness of extracorporeal photochemotherapy in the treatment of a case of refractory erosive lichen planus.
|
J Dermatolog Treat
|
2010
|
0.75
|
|
37
|
Flow cytometry immunophenotyping in mycosis fungoides.
|
J Am Acad Dermatol
|
2008
|
0.75
|
|
38
|
What is the role of sequential reverse-transcriptase polymerase chain reaction analysis of melanoma-specific mRNA in the peripheral blood of melanoma patients?
|
J Clin Oncol
|
2007
|
0.75
|
|
39
|
A retrospective analysis of the costs and management of genital warts in Italy.
|
BMC Infect Dis
|
2013
|
0.75
|
|
40
|
Clinical significance of sequential tyrosinase expression in the peripheral blood of disease-free melanoma patients: a review of literature data.
|
Melanoma Res
|
2004
|
0.75
|
|
41
|
We are very happy and proud of this monographic issue of the Giornale Italiano di Dermatologia e Venereologia. Introduction.
|
G Ital Dermatol Venereol
|
2012
|
0.75
|
|
42
|
Prevalence and significance of human parvovirus variants in skin from primary cutaneous T cell lymphomas, inflammatory dermatoses and healthy subjects.
|
Arch Dermatol Res
|
2009
|
0.75
|
|
43
|
Adult-onset cutaneous mastocytosis in monozygotic twins.
|
J Am Acad Dermatol
|
2011
|
0.75
|
|
44
|
TCRgamma-chain gene rearrangement by GeneScan: incidence and significance of clonal heterogeneity in Sézary syndrome.
|
J Invest Dermatol
|
2010
|
0.75
|
|
45
|
Variants of parvovirus B19: bioinformatical evaluation of nested PCR assays.
|
Intervirology
|
2008
|
0.75
|
|
46
|
Melanoma density and relationship with the distribution of melanocytic naevi in an Italian population: a GIPMe study--the Italian multidisciplinary group on melanoma.
|
Melanoma Res
|
2015
|
0.75
|
|
47
|
Improved Anti-Tumoral Therapeutic Efficacy of 4-Hydroxynonenal Incorporated in Novel Lipid Nanocapsules in 2D and 3D Models.
|
J Biomed Nanotechnol
|
2015
|
0.75
|
|
48
|
High-dose immunoglobulines and extracorporeal photochemotherapy in the treatment of febrile ulceronecrotic Mucha-Habermann disease.
|
Dermatol Ther
|
2010
|
0.75
|
|
49
|
Long-term evolution of an untreated primary cutaneous follicle center lymphoma of the scalp.
|
Am J Dermatopathol
|
2010
|
0.75
|
|
50
|
Cutaneous intravascular lymphoma following extravascular lymphoma of the lung.
|
Dermatology
|
2004
|
0.75
|
|
51
|
Atopic dermatitis in a phenylketonuric untreated patient.
|
Int J Dermatol
|
2013
|
0.75
|